首页 > 最新文献

Hpb最新文献

英文 中文
Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study. 胰腺切除术治疗神经内分泌肿瘤的理想预后:一项全国性研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-07 DOI: 10.1016/j.hpb.2024.12.024
Jeffrey W Chen, Simone A Augustinus, Bert A Bonsing, Stefan A W Bouwense, Ignace H J T De Hingh, Casper H Van Eijck, Bas Groot Koerkamp, Tessa E Hendriks, Anton F Engelsman, Marc G Besselink, Els J M Nieveen van Dijkum

Background: Pancreatic resections for pancreatic neuroendocrine tumors (pNET) may experience a higher complication rate than for pancreatic ductal adenocarcinoma (PDAC). This study aimed to determine the rate of the novel composite "Ideal Outcome" measure after resection for pNET, using PDAC as reference.

Methods: This observational cohort study included all consecutive patients after pancreatic resection for pNET and PDAC using the nationwide Dutch Pancreatic Cancer Audit (2014-2021). The primary outcome was Ideal Outcome; absence of postoperative mortality, postoperative pancreatic fistulas (POPF) grade B/C, other major complications, prolonged length of stay, reoperations and readmissions.

Results: In total, 524 pNET and 2851 PDAC resections were included. The rate of Ideal Outcome was lower after resection for pNET (47.7% versus 55.7%; P<0.001) as compared to PDAC. This difference was driven by a lower rate of Ideal Outcome after pancreatoduodenectomy for pNET (37.7% versus 56.3%; P<0.001), with no difference after left pancreatectomy (54.5% versus 52.5%; P=0.598). Among the individual components of Ideal Outcome after pancreatoduodenectomy, the largest difference was a four times higher rate of POPF (32.1% versus 7.9%; P<0.001) after resection of pNET.

Conclusion: Patients undergoing pancreatoduodenectomy for pNET have a reduced Ideal Outcome rate compared to patients with PDAC, related to a fourfold increased risk of POPF. This highlights the value of pNET-specific patient counseling and the need for effective POPF mitigation strategies.

背景:胰腺神经内分泌肿瘤(pNET)切除术可能比胰腺导管腺癌(PDAC)有更高的并发症发生率。本研究旨在确定pNET切除术后新型复合“理想预后”测量的比率,以PDAC为参考。方法:本观察性队列研究纳入了荷兰全国胰腺癌审计(2014-2021)中因pNET和PDAC进行胰腺切除术后的所有连续患者。主要结局为理想结局;无术后死亡率、术后胰瘘(POPF) B/C级、其他主要并发症、住院时间延长、再手术和再入院。结果:共纳入524例pNET和2851例PDAC切除术。pNET切除术后理想预后率较低(47.7%比55.7%;结论:与PDAC患者相比,接受胰十二指肠切除术的pNET患者的理想转归率降低,与POPF风险增加4倍相关。这突出了pnet特异性患者咨询的价值以及有效的POPF缓解策略的必要性。
{"title":"Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study.","authors":"Jeffrey W Chen, Simone A Augustinus, Bert A Bonsing, Stefan A W Bouwense, Ignace H J T De Hingh, Casper H Van Eijck, Bas Groot Koerkamp, Tessa E Hendriks, Anton F Engelsman, Marc G Besselink, Els J M Nieveen van Dijkum","doi":"10.1016/j.hpb.2024.12.024","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.12.024","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic resections for pancreatic neuroendocrine tumors (pNET) may experience a higher complication rate than for pancreatic ductal adenocarcinoma (PDAC). This study aimed to determine the rate of the novel composite \"Ideal Outcome\" measure after resection for pNET, using PDAC as reference.</p><p><strong>Methods: </strong>This observational cohort study included all consecutive patients after pancreatic resection for pNET and PDAC using the nationwide Dutch Pancreatic Cancer Audit (2014-2021). The primary outcome was Ideal Outcome; absence of postoperative mortality, postoperative pancreatic fistulas (POPF) grade B/C, other major complications, prolonged length of stay, reoperations and readmissions.</p><p><strong>Results: </strong>In total, 524 pNET and 2851 PDAC resections were included. The rate of Ideal Outcome was lower after resection for pNET (47.7% versus 55.7%; P<0.001) as compared to PDAC. This difference was driven by a lower rate of Ideal Outcome after pancreatoduodenectomy for pNET (37.7% versus 56.3%; P<0.001), with no difference after left pancreatectomy (54.5% versus 52.5%; P=0.598). Among the individual components of Ideal Outcome after pancreatoduodenectomy, the largest difference was a four times higher rate of POPF (32.1% versus 7.9%; P<0.001) after resection of pNET.</p><p><strong>Conclusion: </strong>Patients undergoing pancreatoduodenectomy for pNET have a reduced Ideal Outcome rate compared to patients with PDAC, related to a fourfold increased risk of POPF. This highlights the value of pNET-specific patient counseling and the need for effective POPF mitigation strategies.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143004795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative liver function imaging and whole genome sequencing - Effective modalities for a new era in personalised decision-making for operable colorectal liver metastases? 定量肝功能成像和全基因组测序——可手术结肠肝转移患者个性化决策的新时代的有效模式?
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-06 DOI: 10.1016/j.hpb.2024.12.023
Fenella Welsh, Senthil Sundaravadanan, Pulkit Sethi, Mohammad Kazeroun, Alessandro Fichera, Irdina Nadziruddin, Sarah J Larkin, Naser Ansari-Pour, Tim Maughan, Michael Brady, Rajarshi Banerjee, Sarah Gooding, Myrddin Rees

Background: The optimal strategy for patients with colorectal liver metastases (CRLM) is unclear. The Precision1 prospective, observational trial assessed whether pre-operative functional imaging and whole genome sequencing (WGS), could enhance individualized decision-making.

Methods: Patients with CRLM considered for hepatectomy were recruited. In addition to standard staging, patients underwent a quantitative multiparametric MRI (mpMRI) scan, to assess liver function. Use of mpMRI to aid surgical decision-making, was prospectively recorded, as were short-term clinical outcomes in patients who underwent hepatectomy. In the first 45 patients, WGS was performed on blood and liver tumour samples collected per-operatively.

Results: 95 mpMRI scans were performed in 84 patients, who underwent 87 resections. The mpMRI scan affected surgical decision-making in 41 % (39/95) of scans, with 11 undergoing dual-vein embolization, 16 undergoing more conservative parenchymal-sparing surgery, 11 having more extensive surgery, and one patient following a low calorie diet pre-operatively. There were significant (Clavien-Dindo grades 3/4) complications in 5 % of patients, no Grade C post-hepatectomy liver failure, and zero 90-day mortality. WGS suggested additional therapeutic options and prognostic factors for 22 of 35 (63 %) evaluable patients.

Conclusion: Precision1 shows mpMRI can aid surgical decision-making, and optimise clinical outcomes. WGS provides additional information, to further enhance personalised decision-making.

背景:结肠直肠肝转移(CRLM)患者的最佳治疗策略尚不清楚。Precision1前瞻性观察性试验评估了术前功能成像和全基因组测序(WGS)是否可以增强个性化决策。方法:纳入考虑行肝切除术的CRLM患者。除了标准分期外,患者还接受了定量多参数MRI (mpMRI)扫描,以评估肝功能。使用mpMRI辅助手术决策的前瞻性记录,以及肝切除术患者的短期临床结果。在前45例患者中,对术前收集的血液和肝脏肿瘤样本进行了WGS。结果:84例患者行mpMRI扫描95次,切除87例。41%(39/95)的mpMRI扫描影响了手术决策,其中11例进行了双静脉栓塞,16例进行了更保守的保留实质性手术,11例进行了更广泛的手术,1例术前低热量饮食。5%的患者有明显的并发症(Clavien-Dindo分级3/4),无肝切除术后C级肝衰竭,90天死亡率为零。WGS对35名可评估患者中的22名(63%)提出了额外的治疗方案和预后因素。结论:Precision1显示mpMRI可以辅助手术决策,优化临床效果。WGS提供了额外的信息,以进一步加强个性化决策。
{"title":"Quantitative liver function imaging and whole genome sequencing - Effective modalities for a new era in personalised decision-making for operable colorectal liver metastases?","authors":"Fenella Welsh, Senthil Sundaravadanan, Pulkit Sethi, Mohammad Kazeroun, Alessandro Fichera, Irdina Nadziruddin, Sarah J Larkin, Naser Ansari-Pour, Tim Maughan, Michael Brady, Rajarshi Banerjee, Sarah Gooding, Myrddin Rees","doi":"10.1016/j.hpb.2024.12.023","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.12.023","url":null,"abstract":"<p><strong>Background: </strong>The optimal strategy for patients with colorectal liver metastases (CRLM) is unclear. The Precision1 prospective, observational trial assessed whether pre-operative functional imaging and whole genome sequencing (WGS), could enhance individualized decision-making.</p><p><strong>Methods: </strong>Patients with CRLM considered for hepatectomy were recruited. In addition to standard staging, patients underwent a quantitative multiparametric MRI (mpMRI) scan, to assess liver function. Use of mpMRI to aid surgical decision-making, was prospectively recorded, as were short-term clinical outcomes in patients who underwent hepatectomy. In the first 45 patients, WGS was performed on blood and liver tumour samples collected per-operatively.</p><p><strong>Results: </strong>95 mpMRI scans were performed in 84 patients, who underwent 87 resections. The mpMRI scan affected surgical decision-making in 41 % (39/95) of scans, with 11 undergoing dual-vein embolization, 16 undergoing more conservative parenchymal-sparing surgery, 11 having more extensive surgery, and one patient following a low calorie diet pre-operatively. There were significant (Clavien-Dindo grades 3/4) complications in 5 % of patients, no Grade C post-hepatectomy liver failure, and zero 90-day mortality. WGS suggested additional therapeutic options and prognostic factors for 22 of 35 (63 %) evaluable patients.</p><p><strong>Conclusion: </strong>Precision1 shows mpMRI can aid surgical decision-making, and optimise clinical outcomes. WGS provides additional information, to further enhance personalised decision-making.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143004811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of vascular injuries on the management of bile duct injury following laparoscopic cholecystectomy- insights from a prospective study. 血管损伤对腹腔镜胆囊切除术后胆管损伤处理的影响——一项前瞻性研究的见解。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-06 DOI: 10.1016/j.hpb.2024.12.022
Rohith Kodali, Utpal Anand, Kunal Parasar, Rajeev N Priyadarshi, Ramesh Kumar, Basant N Singh, Kislay Kant

Background: Our study aimed to compare the clinical presentation and outcomes of post-cholecystectomy bile duct injuries (BDI) with and without arterial injuries.

Methods: A prospective analysis of 123 patients with post-cholecystectomy BDI between July 2018 and January 2022 was performed. Multivariate logistic regression analysis was used to assess the impact of vascular injuries on perioperative complications and long-term outcomes after delayed repair.

Results: Of 123 patients, 42 (34%) had associated vascular injuries, predominantly right hepatic artery disruptions. These patients experienced significantly higher perioperative complications after the index surgery (Cholangiolar abscess- 83.3% vs 32.1% ( p<0.001), recurrent cholangitis- 66.67 % vs 14.81 % ( p<0.001), blood transfusions ³2 - 89.74 % vs 28.57 % ( p<0.001), hospital admissions ³3 - 3.88 ± 1.99 vs 2.49 ± 0.74 ( p<0.001). Delayed Hepp-Couinaud biliary repair was performed in 112 patients. After a median follow-up, of 2 years, 85 (51.43 % vs. 88.16 % ), 12 (25.71 % vs. 3.89 %), 6 (11.43 % vs. 2.59 %), and 9 (11.43 % vs. 6.49 %) patients had excellent, good, fair, and poor outcomes.

Conclusion: Concomitant vasculobiliary injuries were associated with increased morbidity after index surgery; however, the long-term outcomes following definitive biliary repair remained comparable.

背景:本研究旨在比较胆囊切除术后胆管损伤(BDI)伴和不伴动脉损伤的临床表现和预后。方法:对2018年7月至2022年1月期间123例胆囊切除术后BDI患者进行前瞻性分析。采用多因素logistic回归分析评估血管损伤对围手术期并发症及延迟修复后远期预后的影响。结果:123例患者中,42例(34%)伴有血管损伤,主要是右肝动脉破裂。这些患者在指数手术后出现了更高的围手术期并发症(胆管脓肿- 83.3% vs 32.1%)。结论:指数手术后并发的血管胆道损伤与发病率增加有关;然而,最终胆道修复后的长期结果仍然具有可比性。
{"title":"The impact of vascular injuries on the management of bile duct injury following laparoscopic cholecystectomy- insights from a prospective study.","authors":"Rohith Kodali, Utpal Anand, Kunal Parasar, Rajeev N Priyadarshi, Ramesh Kumar, Basant N Singh, Kislay Kant","doi":"10.1016/j.hpb.2024.12.022","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.12.022","url":null,"abstract":"<p><strong>Background: </strong>Our study aimed to compare the clinical presentation and outcomes of post-cholecystectomy bile duct injuries (BDI) with and without arterial injuries.</p><p><strong>Methods: </strong>A prospective analysis of 123 patients with post-cholecystectomy BDI between July 2018 and January 2022 was performed. Multivariate logistic regression analysis was used to assess the impact of vascular injuries on perioperative complications and long-term outcomes after delayed repair.</p><p><strong>Results: </strong>Of 123 patients, 42 (34%) had associated vascular injuries, predominantly right hepatic artery disruptions. These patients experienced significantly higher perioperative complications after the index surgery (Cholangiolar abscess- 83.3% vs 32.1% ( p<0.001), recurrent cholangitis- 66.67 % vs 14.81 % ( p<0.001), blood transfusions ³2 - 89.74 % vs 28.57 % ( p<0.001), hospital admissions ³3 - 3.88 ± 1.99 vs 2.49 ± 0.74 ( p<0.001). Delayed Hepp-Couinaud biliary repair was performed in 112 patients. After a median follow-up, of 2 years, 85 (51.43 % vs. 88.16 % ), 12 (25.71 % vs. 3.89 %), 6 (11.43 % vs. 2.59 %), and 9 (11.43 % vs. 6.49 %) patients had excellent, good, fair, and poor outcomes.</p><p><strong>Conclusion: </strong>Concomitant vasculobiliary injuries were associated with increased morbidity after index surgery; however, the long-term outcomes following definitive biliary repair remained comparable.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143004813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors associated with venous thromboembolism after hepatectomy in oncology patients.
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-04 DOI: 10.1016/j.hpb.2024.12.021
Brianna Greenberg, Alexandra W Acher, Alejandro Branes, Rachel Roke, Grace Xu, Myriam Lafreniere-Roula, Kevin Thorpe, Keying Xu, Paul J Karanicolas

Background: Liver resection increases venous thromboembolism (VTE) risk due to malignancy-related hyper-coagulopathy and surgical inflammation. Current guidelines recommend early post-operative and extended pharmacologic prophylaxis for all patients but lack stratification by patient or surgical factors. Despite these guidelines, surgeon preferences influence prophylaxis practices. This study aimed to identify clinical factors associated with VTE following liver resection.

Methods: Using data from the Hemorrhage During Liver Resection (HeLiX) trial, a randomized clinical trial of patients undergoing liver resection for cancer, univariate comparisons and logistic regression were performed.

Results: Study cohort VTE incidence was 4.1 %. Multivariable analysis identified major liver resection (odds ratio (OR) 2.59, 95 % confidence interval (CI) 1.38-5.03) and higher estimated blood loss (EBL) (OR 1.14 per 500 mL increase, 95 % CI 1.03-1.26) as associated with increased risk. Surgical duration (OR 1.14 per hour increase, 95 % CI 0.95-1.34) and use of tranexamic acid (OR 1.77, 95 % CI 0.98-3.27) did not reach statistical significance. VTE rate was highly dependent on extent of resection (1-2 segments, 1.7 %; 3-4 segments, 5.4 %; >4 segments, 6.7 %).

Conclusion: Major resection and increased EBL are associated with higher risk of VTE. These patients may warrant more intensive prophylax compared to those having minor resections with minimal blood loss.

{"title":"Risk factors associated with venous thromboembolism after hepatectomy in oncology patients.","authors":"Brianna Greenberg, Alexandra W Acher, Alejandro Branes, Rachel Roke, Grace Xu, Myriam Lafreniere-Roula, Kevin Thorpe, Keying Xu, Paul J Karanicolas","doi":"10.1016/j.hpb.2024.12.021","DOIUrl":"https://doi.org/10.1016/j.hpb.2024.12.021","url":null,"abstract":"<p><strong>Background: </strong>Liver resection increases venous thromboembolism (VTE) risk due to malignancy-related hyper-coagulopathy and surgical inflammation. Current guidelines recommend early post-operative and extended pharmacologic prophylaxis for all patients but lack stratification by patient or surgical factors. Despite these guidelines, surgeon preferences influence prophylaxis practices. This study aimed to identify clinical factors associated with VTE following liver resection.</p><p><strong>Methods: </strong>Using data from the Hemorrhage During Liver Resection (HeLiX) trial, a randomized clinical trial of patients undergoing liver resection for cancer, univariate comparisons and logistic regression were performed.</p><p><strong>Results: </strong>Study cohort VTE incidence was 4.1 %. Multivariable analysis identified major liver resection (odds ratio (OR) 2.59, 95 % confidence interval (CI) 1.38-5.03) and higher estimated blood loss (EBL) (OR 1.14 per 500 mL increase, 95 % CI 1.03-1.26) as associated with increased risk. Surgical duration (OR 1.14 per hour increase, 95 % CI 0.95-1.34) and use of tranexamic acid (OR 1.77, 95 % CI 0.98-3.27) did not reach statistical significance. VTE rate was highly dependent on extent of resection (1-2 segments, 1.7 %; 3-4 segments, 5.4 %; >4 segments, 6.7 %).</p><p><strong>Conclusion: </strong>Major resection and increased EBL are associated with higher risk of VTE. These patients may warrant more intensive prophylax compared to those having minor resections with minimal blood loss.</p>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights in this issue
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-01 DOI: 10.1016/S1365-182X(24)02438-9
{"title":"Highlights in this issue","authors":"","doi":"10.1016/S1365-182X(24)02438-9","DOIUrl":"10.1016/S1365-182X(24)02438-9","url":null,"abstract":"","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 1","pages":"Page iii"},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143102649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in the detection of choledocholithiasis: a systematic review 人工智能在胆总管结石检测中的应用:系统综述。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-01 DOI: 10.1016/j.hpb.2024.09.009
Joshua Blum , Lewis Wood , Richard Turner

Importance

Choledocholithiasis is a potentially life-threatening manifestation of acute biliary dysfunction (ABD) often requiring magnetic resonance cholangiopancreatography (MRCP) for diagnosis when standard investigation findings are inconclusive. Machine learning models (MLMs) may offer alternatives to diagnose choledocholithiasis.

Objective

This systematic review seeks to evaluate the performance of MLMs in predicting choledocholithiasis and to compare this performance with the American Society of Gastrointestinal Endoscopy (ASGE) guidelines.

Review

This review adhered to PRISMA guidelines. Four databases were searched for relevant records published between January 2000 and April 2024. Two researchers appraised records. MLM performance and ASGE guideline efficacy were compared, and the clinical utility of MLMs was assessed.

Findings

408 records were screened; eight were eligible. Model accuracy ranged from 19 % to 97 %. Several records demonstrated a moderate-to-high risk of bias; of those featuring low risk of bias, peak accuracies ranged from 70 % to 85 %. Most MLMs outperformed ASGE guidelines. Important predictor variables included age, total bilirubin, and common bile duct diameter.

Conclusions

MLMs outperform ASGE guidelines in predicting choledocholithiasis. Nonetheless, biases in study design and reporting limit their prospective applicability. Current MLMs do not yet rival MRCP in detecting choledocholithiasis. Future guideline development should consider MLM-driven insights for better risk prediction.
重要性:胆总管结石是急性胆道功能障碍(ABD)的一种可能危及生命的表现,当标准检查结果不确定时,往往需要进行磁共振胆胰管造影(MRCP)来诊断。机器学习模型(MLM)可作为诊断胆总管结石的替代方法:本系统综述旨在评估机器学习模型在预测胆总管结石方面的性能,并将其与美国消化内镜学会(ASGE)指南进行比较:本综述遵循 PRISMA 指南。我们在四个数据库中搜索了2000年1月至2024年4月期间发表的相关记录。两名研究人员对记录进行了评估。比较了MLM的性能和ASGE指南的有效性,并评估了MLM的临床实用性:筛选了 408 条记录,其中 8 条符合条件。模型准确率从 19% 到 97% 不等。一些记录显示存在中度到高度的偏倚风险;在偏倚风险较低的记录中,峰值准确率介于 70% 到 85% 之间。大多数 MLM 都优于 ASGE 指南。重要的预测变量包括年龄、总胆红素和胆总管直径:结论:MLM 在预测胆总管结石方面优于 ASGE 指南。尽管如此,研究设计和报告中的偏差限制了其前瞻性的适用性。在检测胆总管结石方面,目前的多导睡眠监测尚不能与 MRCP 相媲美。未来的指南制定应考虑以 MLM 为导向,以更好地预测风险。
{"title":"Artificial intelligence in the detection of choledocholithiasis: a systematic review","authors":"Joshua Blum ,&nbsp;Lewis Wood ,&nbsp;Richard Turner","doi":"10.1016/j.hpb.2024.09.009","DOIUrl":"10.1016/j.hpb.2024.09.009","url":null,"abstract":"<div><h3>Importance</h3><div>Choledocholithiasis is a potentially life-threatening manifestation of acute biliary dysfunction (ABD) often requiring magnetic resonance cholangiopancreatography (MRCP) for diagnosis when standard investigation findings are inconclusive. Machine learning models (MLMs) may offer alternatives to diagnose choledocholithiasis.</div></div><div><h3>Objective</h3><div>This systematic review seeks to evaluate the performance of MLMs in predicting choledocholithiasis and to compare this performance with the American Society of Gastrointestinal Endoscopy (ASGE) guidelines.</div></div><div><h3>Review</h3><div>This review adhered to PRISMA guidelines. Four databases were searched for relevant records published between January 2000 and April 2024. Two researchers appraised records. MLM performance and ASGE guideline efficacy were compared, and the clinical utility of MLMs was assessed.</div></div><div><h3>Findings</h3><div>408 records were screened; eight were eligible. Model accuracy ranged from 19 % to 97 %. Several records demonstrated a moderate-to-high risk of bias; of those featuring low risk of bias, peak accuracies ranged from 70 % to 85 %. Most MLMs outperformed ASGE guidelines. Important predictor variables included age, total bilirubin, and common bile duct diameter.</div></div><div><h3>Conclusions</h3><div>MLMs outperform ASGE guidelines in predicting choledocholithiasis. Nonetheless, biases in study design and reporting limit their prospective applicability. Current MLMs do not yet rival MRCP in detecting choledocholithiasis. Future guideline development should consider MLM-driven insights for better risk prediction.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 1","pages":"Pages 1-9"},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning curve in robotic liver surgery: easily achievable, evolving from laparoscopic background and team-based 机器人肝脏手术的学习曲线:容易实现,从腹腔镜背景发展而来,以团队为基础。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-01 DOI: 10.1016/j.hpb.2024.10.007
Francesca Ratti , Sara Ingallinella , Marco Catena , Diletta Corallino , Rebecca Marino , Luca Aldrighetti

Background

Limited and heterogeneous literature data necessitate a focused examination of the learning curve in robotic liver resections. This study aims to assess the learning curve of two surgeons from the same team with differing laparoscopic backgrounds.

Methods

Since February 2021, San Raffaele Hospital in Milan has implemented a robotic liver surgery program, performing 250 resections by three trained console surgeons. Using cumulative sum (CUSUM) analysis, the learning curve was evaluated for a Pioneer Surgeon (PS) with around 1200 laparoscopic cases and a New Generation Surgeon (NGS) with approximately 100 laparoscopic cases. Cases were stratified by complexity (38 low, 74 intermediate, 85 high).

Results

Both PS and NGS demonstrated a learning curve for operative time after 15 low-complexity and 10 intermediate-complexity cases, with high-complexity learning curves apparent after 10 cases for PS and 18 cases for NGS. Conversion rates remained unaffected, and neither surgeon experienced increased blood loss or postoperative complications. A “team learning curve” effect in terms of operative time emerged after 12 cases, suggesting the importance of a cohesive surgical team.

Conclusion

The robotic platform facilitated a relatively brief learning curve for low and intermediate complexity cases, irrespective of laparoscopic background, underscoring the benefits of team collaboration.
背景:由于文献资料有限且不尽相同,有必要对机器人肝脏切除术的学习曲线进行重点研究。本研究旨在评估来自同一团队、具有不同腹腔镜背景的两名外科医生的学习曲线:自 2021 年 2 月起,米兰圣拉斐尔医院开始实施机器人肝脏手术项目,由三名训练有素的控制台外科医生实施了 250 例切除手术。通过累积总和(CUSUM)分析法,对拥有约1200例腹腔镜手术的先锋外科医生(PS)和拥有约100例腹腔镜手术的新一代外科医生(NGS)的学习曲线进行了评估。病例按复杂程度分层(38 个低复杂病例、74 个中等复杂病例、85 个高复杂病例):结果:PS 和 NGS 在 15 例低度复杂病例和 10 例中度复杂病例后都显示出手术时间学习曲线,PS 在 10 例病例后和 NGS 在 18 例病例后显示出高度复杂病例学习曲线。转换率未受影响,两位外科医生的失血量和术后并发症均未增加。12 个病例后,在手术时间方面出现了 "团队学习曲线 "效应,这表明一个团结的手术团队非常重要:机器人平台为中低复杂度病例提供了相对较短的学习曲线,无论其腹腔镜背景如何,这凸显了团队合作的益处。
{"title":"Learning curve in robotic liver surgery: easily achievable, evolving from laparoscopic background and team-based","authors":"Francesca Ratti ,&nbsp;Sara Ingallinella ,&nbsp;Marco Catena ,&nbsp;Diletta Corallino ,&nbsp;Rebecca Marino ,&nbsp;Luca Aldrighetti","doi":"10.1016/j.hpb.2024.10.007","DOIUrl":"10.1016/j.hpb.2024.10.007","url":null,"abstract":"<div><h3>Background</h3><div>Limited and heterogeneous literature data necessitate a focused examination of the learning curve in robotic liver resections. This study aims to assess the learning curve of two surgeons from the same team with differing laparoscopic backgrounds.</div></div><div><h3>Methods</h3><div>Since February 2021, San Raffaele Hospital in Milan has implemented a robotic liver surgery program, performing 250 resections by three trained console surgeons. Using cumulative sum (CUSUM) analysis, the learning curve was evaluated for a Pioneer Surgeon (PS) with around 1200 laparoscopic cases and a New Generation Surgeon (NGS) with approximately 100 laparoscopic cases. Cases were stratified by complexity (38 low, 74 intermediate, 85 high).</div></div><div><h3>Results</h3><div>Both PS and NGS demonstrated a learning curve for operative time after 15 low-complexity and 10 intermediate-complexity cases, with high-complexity learning curves apparent after 10 cases for PS and 18 cases for NGS. Conversion rates remained unaffected, and neither surgeon experienced increased blood loss or postoperative complications. A “team learning curve” effect in terms of operative time emerged after 12 cases, suggesting the importance of a cohesive surgical team.</div></div><div><h3>Conclusion</h3><div>The robotic platform facilitated a relatively brief learning curve for low and intermediate complexity cases, irrespective of laparoscopic background, underscoring the benefits of team collaboration.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 1","pages":"Pages 45-55"},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142590681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is robotic liver resection feasible in patients with lesions in close proximity to major vessels? A propensity score matching analysis 病变靠近大血管的患者是否可行机器人肝脏切除术?倾向得分匹配分析
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-01 DOI: 10.1016/j.hpb.2024.09.010
Edoardo M. Muttillo , Leonardo L. Chiarella , Francesca Ratti , Paolo Magistri , Andrea Belli , Giammauro Berardi , Giuseppe M. Ettorre , Graziano Ceccarelli , Francesco Izzo , Marcello G. Spampinato , Nicola De Angelis , Patrick Pessaux , Tullio Piardi , Fabrizio Di Benedetto , Luca Aldrighetti , Riccardo Memeo

Introduction

Robotic surgery is widely diffused in the surgical field and is becoming increasingly prevalent, however several aspects need more detailed assessment. One of them concerns the role of robotic liver surgery for lesions in contact with major vascular (CMV) pedicles. The aim of our study is to evaluate and compare intra and post operative outcomes in patients undergoing robotic liver resections between lesions in contact or free from major vessels.

Methods

A multicentric retrospective study was performed including 1030 patients who underwent robotic liver resection. Patients were divided into two groups according to vascular contact. Intra and post-operative outcomes were compared between the groups before and after Propensity Score Matching.

Results

After propensity score matching 889 patients were included in the study. Among these lesions, 595 were not in contact with major vessels (NCMV) and 294 were in contact with major vessels (CMV). Use of Pringle Manoeuvre was more associated with CMV resections (49.8 % vs 31.2 %, p = 0,0001). No differences in terms of operative time, conversion rate, morbidity and type of complications were observed after PSM.

Conclusion

The presents study shows how robotic surgery is a valid and safe technique also for resection of tumors close to vascular pedicles.
导言:机器人手术已广泛应用于外科领域,并日益普及,但有几个方面需要更详细的评估。其中一个方面涉及到机器人肝脏手术在治疗与大血管(CMV)血管蒂接触的病变方面的作用。我们的研究旨在评估和比较接受机器人肝脏切除术的患者在接触或不接触大血管的病变中的术中和术后效果:我们进行了一项多中心回顾性研究,包括 1030 名接受机器人肝脏切除术的患者。根据血管接触情况将患者分为两组。比较了倾向得分匹配前后两组患者的术中和术后结果:经过倾向评分匹配后,889 名患者被纳入研究。在这些病变中,595 例未与大血管接触(NCMV),294 例与大血管接触(CMV)。使用普林格尔手法(Pringle Manoeuvre)与CMV切除术更相关(49.8% vs 31.2%,p = 0,0001)。PSM术后在手术时间、转换率、发病率和并发症类型方面均无差异:本研究表明,机器人手术对于切除靠近血管蒂的肿瘤也是一种有效而安全的技术。
{"title":"Is robotic liver resection feasible in patients with lesions in close proximity to major vessels? A propensity score matching analysis","authors":"Edoardo M. Muttillo ,&nbsp;Leonardo L. Chiarella ,&nbsp;Francesca Ratti ,&nbsp;Paolo Magistri ,&nbsp;Andrea Belli ,&nbsp;Giammauro Berardi ,&nbsp;Giuseppe M. Ettorre ,&nbsp;Graziano Ceccarelli ,&nbsp;Francesco Izzo ,&nbsp;Marcello G. Spampinato ,&nbsp;Nicola De Angelis ,&nbsp;Patrick Pessaux ,&nbsp;Tullio Piardi ,&nbsp;Fabrizio Di Benedetto ,&nbsp;Luca Aldrighetti ,&nbsp;Riccardo Memeo","doi":"10.1016/j.hpb.2024.09.010","DOIUrl":"10.1016/j.hpb.2024.09.010","url":null,"abstract":"<div><h3>Introduction</h3><div>Robotic surgery is widely diffused in the surgical field and is becoming increasingly prevalent, however several aspects need more detailed assessment. One of them concerns the role of robotic liver surgery for lesions in contact with major vascular (CMV) pedicles. The aim of our study is to evaluate and compare intra and post operative outcomes in patients undergoing robotic liver resections between lesions in contact or free from major vessels.</div></div><div><h3>Methods</h3><div>A multicentric retrospective study was performed including 1030 patients who underwent robotic liver resection. Patients were divided into two groups according to vascular contact. Intra and post-operative outcomes were compared between the groups before and after Propensity Score Matching.</div></div><div><h3>Results</h3><div>After propensity score matching 889 patients were included in the study. Among these lesions, 595 were not in contact with major vessels (NCMV) and 294 were in contact with major vessels (CMV). Use of Pringle Manoeuvre was more associated with CMV resections (49.8 % vs 31.2 %, p = 0,0001). No differences in terms of operative time, conversion rate, morbidity and type of complications were observed after PSM.</div></div><div><h3>Conclusion</h3><div>The presents study shows how robotic surgery is a valid and safe technique also for resection of tumors close to vascular pedicles.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 1","pages":"Pages 21-28"},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined division of the splenic vessels and pancreatic parenchyma during laparoscopic distal pancreatectomy is a safe alternative to separate division: a single-institution retrospective study 腹腔镜胰腺远端切除术中合并分割脾血管和胰腺实质是一种安全的替代单独分割的方法:一项单一机构的回顾性研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-01 DOI: 10.1016/j.hpb.2024.10.002
Kareem Sadek, Andrew Shaker, Mary Tice, John A. Stauffer

Background

Limited data exists regarding the safety and outcomes of combined division of the splenic vessels with the pancreatic parenchyma during laparoscopic distal pancreatectomy (LDP). This study aims to evaluate the combined division technique.

Methods

Patients who underwent LDP for pancreatic cancer from April 2011 to December 2022 were retrospectively reviewed and categorized into the following groups: combined (CV) versus separate (SV) division of the splenic vein; combined (CA) versus separate (SA) division of the splenic artery; and combined (CAV) versus separate (SAV) division of the splenic artery and vein, with or without the pancreatic parenchyma.

Results

Among the 80 patients included, 44 underwent CV and 36 underwent SV. Operative time and major morbidity were significantly lower in CV compared with SV. Similar findings were observed in CAV versus SAV, as well as lower blood loss in CAV. Operative time was significantly lower in CA versus SA. Pancreatic fistula and postpancreatectomy hemorrhage rates showed no significant differences between groups. No patient developed splenic arteriovenous fistula in follow-up.

Conclusion

Combined division of the splenic vessels with the pancreatic parenchyma during LDP is safe and associated with improved outcomes compared with separate division.
背景:有关腹腔镜胰腺远端切除术(LDP)中脾血管与胰腺实质联合分割的安全性和结果的数据有限。本研究旨在评估联合分割技术:回顾性研究2011年4月至2022年12月期间因胰腺癌接受腹腔镜胰腺切除术的患者,并将其分为以下几组:脾静脉联合(CV)与单独(SV)分割;脾动脉联合(CA)与单独(SA)分割;脾动脉与静脉联合(CAV)与单独(SAV)分割,有无胰腺实质:在纳入的 80 位患者中,44 位接受了 CV,36 位接受了 SV。与 SV 相比,CV 的手术时间和主要发病率明显较低。CAV与SAV的结果相似,CAV的失血量更低。CA与SA相比,手术时间明显更短。胰瘘和胰腺切除术后出血率在组间无明显差异。随访中没有患者出现脾动静脉瘘:结论:在 LDP 期间将脾血管与胰腺实质合并分割是安全的,与单独分割相比,其结果更好。
{"title":"Combined division of the splenic vessels and pancreatic parenchyma during laparoscopic distal pancreatectomy is a safe alternative to separate division: a single-institution retrospective study","authors":"Kareem Sadek,&nbsp;Andrew Shaker,&nbsp;Mary Tice,&nbsp;John A. Stauffer","doi":"10.1016/j.hpb.2024.10.002","DOIUrl":"10.1016/j.hpb.2024.10.002","url":null,"abstract":"<div><h3>Background</h3><div>Limited data exists regarding the safety and outcomes of combined division of the splenic vessels with the pancreatic parenchyma during laparoscopic distal pancreatectomy (LDP). This study aims to evaluate the combined division technique.</div></div><div><h3>Methods</h3><div>Patients who underwent LDP for pancreatic cancer from April 2011 to December 2022 were retrospectively reviewed and categorized into the following groups: combined (CV) versus separate (SV) division of the splenic vein; combined (CA) versus separate (SA) division of the splenic artery; and combined (CAV) versus separate (SAV) division of the splenic artery and vein, with or without the pancreatic parenchyma.</div></div><div><h3>Results</h3><div>Among the 80 patients included, 44 underwent CV and 36 underwent SV. Operative time and major morbidity were significantly lower in CV compared with SV. Similar findings were observed in CAV versus SAV, as well as lower blood loss in CAV. Operative time was significantly lower in CA versus SA. Pancreatic fistula and postpancreatectomy hemorrhage rates showed no significant differences between groups. No patient developed splenic arteriovenous fistula in follow-up.</div></div><div><h3>Conclusion</h3><div>Combined division of the splenic vessels with the pancreatic parenchyma during LDP is safe and associated with improved outcomes compared with separate division.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 1","pages":"Pages 80-86"},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nationwide analysis of one-year mortality following pancreatectomy in 17,183 patients with pancreatic cancer 对 17,183 名胰腺癌患者进行胰腺切除术后一年死亡率的全国性分析。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Hpb
Pub Date : 2025-01-01 DOI: 10.1016/j.hpb.2024.10.011
Ugo Marchese , Xavier Lenne , Gaanan Naveendran , Stylianos Tzedakis , Martin Gaillard , Yasmina Richa , Laurent Boyer , Didier Theis , Amelie Bruandet , Stephanie Truant , David Fuks , Mehdi EL Amrani

Background

The use of 1-year mortality following pancreatectomy for PDAC as a measure of surgical quality has not been evaluated. We aim to i) assess the 1-year mortality rate following pancreatectomy for PDAC, and ii) identify patient and hospital characteristics associated with 1-year mortality.

Methods

Data was extracted retrospectively from the French national medico-administrative database. The study included patients who underwent pancreatectomy for PDAC between January 2012 and December 2019. The primary outcome was 1-year postoperative mortality. Hospitals were classified based on volume (high (≥26 resections/year) and low volume (<26)).

Results

Overall, 17,183 patients who underwent pancreatectomy for PDAC were included. The overall 90-day and 1-year mortalities were 6.5 % and 21.5 %, respectively. 1-year mortality varied significantly between low and high-volume hospitals (23.6 % vs. 18.6 %, respectively, p < 0.001). Older age, Charlson Comorbidity Index (CCI), readmission, major complications were predictive factors for 1-year mortality. Pancreatectomy in low volume hospitals increased the risk of 1-year mortality by 1.23-fold (OR = 1.23, 95 % CI [1.15–1.32], p < 0.001).

Conclusion

The overall 1-year mortality after pancreatectomy for PDAC was 21.5 %, and was higher in patients of older age, with higher comorbidities, who experienced major complications, and who did not receive adjuvant therapy. Management in high-volume centers decreased mortality rates, regardless of the patient’s condition.
背景:将 PDAC 胰腺切除术后 1 年死亡率作为手术质量的衡量标准尚未进行评估。我们的目的是:i)评估 PDAC 胰腺切除术后 1 年的死亡率;ii)确定与 1 年死亡率相关的患者和医院特征:方法:从法国国家医疗行政数据库中回顾性提取数据。研究对象包括2012年1月至2019年12月期间因PDAC接受胰腺切除术的患者。主要结果是术后1年死亡率。根据医院的手术量(高手术量(≥26例切除术/年)和低手术量(结果:共纳入17183名因PDAC接受胰腺切除术的患者。90天和1年总死亡率分别为6.5%和21.5%。低流量医院和高流量医院的 1 年死亡率差异很大(分别为 23.6% 和 18.6%,P 结语):PDAC胰腺切除术后1年总死亡率为21.5%,年龄较大、合并症较多、出现主要并发症和未接受辅助治疗的患者死亡率较高。无论患者病情如何,在高流量中心进行治疗都能降低死亡率。
{"title":"Nationwide analysis of one-year mortality following pancreatectomy in 17,183 patients with pancreatic cancer","authors":"Ugo Marchese ,&nbsp;Xavier Lenne ,&nbsp;Gaanan Naveendran ,&nbsp;Stylianos Tzedakis ,&nbsp;Martin Gaillard ,&nbsp;Yasmina Richa ,&nbsp;Laurent Boyer ,&nbsp;Didier Theis ,&nbsp;Amelie Bruandet ,&nbsp;Stephanie Truant ,&nbsp;David Fuks ,&nbsp;Mehdi EL Amrani","doi":"10.1016/j.hpb.2024.10.011","DOIUrl":"10.1016/j.hpb.2024.10.011","url":null,"abstract":"<div><h3>Background</h3><div>The use of 1-year mortality following pancreatectomy for PDAC as a measure of surgical quality has not been evaluated. We aim to i) assess the 1-year mortality rate following pancreatectomy for PDAC, and ii) identify patient and hospital characteristics associated with 1-year mortality.</div></div><div><h3>Methods</h3><div>Data was extracted retrospectively from the French national medico-administrative database. The study included patients who underwent pancreatectomy for PDAC between January 2012 and December 2019. The primary outcome was 1-year postoperative mortality. Hospitals were classified based on volume (high (≥26 resections/year) and low volume (&lt;26)).</div></div><div><h3>Results</h3><div>Overall, 17,183 patients who underwent pancreatectomy for PDAC were included. The overall 90-day and 1-year mortalities were 6.5 % and 21.5 %, respectively. 1-year mortality varied significantly between low and high-volume hospitals (23.6 % vs. 18.6 %, respectively, <em>p</em> &lt; 0.001). Older age, Charlson Comorbidity Index (CCI), readmission, major complications were predictive factors for 1-year mortality. Pancreatectomy in low volume hospitals increased the risk of 1-year mortality by 1.23-fold (OR = 1.23, 95 % CI [1.15–1.32], <em>p</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>The overall 1-year mortality after pancreatectomy for PDAC was 21.5 %, and was higher in patients of older age, with higher comorbidities, who experienced major complications, and who did not receive adjuvant therapy. Management in high-volume centers decreased mortality rates, regardless of the patient’s condition.</div></div>","PeriodicalId":13229,"journal":{"name":"Hpb","volume":"27 1","pages":"Pages 123-129"},"PeriodicalIF":2.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hpb
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1